Jesper Lind
No más puestos en curso
Perfil
Jesper Lind worked as an Engineer at Alfa Laval AB and as Head-Enabling Capability at AstraZeneca AB.
He then served as Chief Operating Officer at Orexo AB from 2013 to 2018 and as Head-Supply at Moberg Pharma AB.
Mr. Lind graduated from The University of Sydney and the Royal Institute of Technology.
Antiguos cargos conocidos de Jesper Lind.
Empresas | Cargo | Fin |
---|---|---|
OREXO AB | Chief Operating Officer | 31/12/2018 |
MOBERG PHARMA AB | Corporate Officer/Principal | - |
ALFA LAVAL AB | Corporate Officer/Principal | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Formación de Jesper Lind.
The University of Sydney | Graduate Degree |
Royal Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ALFA LAVAL AB | Producer Manufacturing |
OREXO AB | Health Technology |
MOBERG PHARMA AB | Health Technology |
Empresas privadas | 1 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Jesper Lind